Form D

View Original Filing

Notice of Exempt Offering of Securities

Item 1. Issuer's Identity

Name of Issuer:
CONTRAFECT CORP
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
2008

Previous Name(s)

  • CONTRAFECT, INC.
Entity Type
CORPORATION

Item 2 Issuer Principal Place of Business and Contact Information

28 WELLS AVENUE
3RD FLOOR
YONKERS, NY 10701
Phone Number: subscription required

Item 3. Related Persons

Name
ROBERT NOWINSKI, PH.D.
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
SOL BARER, PH.D.
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
SIR RICHARD SYKES, FRS
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
ISSAC BLECH
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
DAVID SCHEINBERG, M.D., PH.D.
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
CARY SUCOFF
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
SHENGDA ZAN
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
JULIA P. GREGORY
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
DAVID HUANG, M.D., PH.D
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
MICHAEL WITTEKIND, PH.D.
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 4. Industry Group

BIOTECHNOLOGY

Item 5. Issuer Size

Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE

Item 6. Federal Exemptions and Exclusions Claimed

Item 7. Type of Filing

New Notice
Date of First Sale in this Offering:
06/18/2013

Item 8. Duration of Offering

Does the issuer intend this offering to last more than one year?
No

Item 9. Type(s) of Securities Offered

  • Debt
  • Option, Warrant or Other Right to Acquire Another Security
  • Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Item 10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response

Item 11. Minimum Investment

Minimum Investment accepted from any outside investor
25000

Item 12. Sales Compensation

Recipient
MAXIM GROUP LLC
Recipient CRD Number
120708
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
405 LEXINGTON AVENUE
NEW YORK, NY 10174
States of Solicitation
  • ALL STATES

Item 13. Offering and Sales Amounts

Total Offering Amount
10000000
Total Amount Sold
9997650
Total Remaining to be Sold
2350
Clarification of Response

Item 14. Investors

Securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
94

Item 15. Sales Commissions and Finders' Fees Expenses

Sales Commissions:
934765.0
Finders' Fees
0.0
Clarification of Response

Item 16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers,directors or promoters in response to Item 3 above.
0.0 Is an estimate
Clarification of Response

Signature and Submission

Issuer Name
CONTRAFECT CORP
Issuer Signature
/S/ ROBERT NOWINSKI
Signer Name
ROBERT NOWINSKI, PH.D.
Signer Title
CHIEF EXECUTIVE OFFICER
Signature Date
06/27/2013
WhaleWisdom Logo

Elevate your investments